Gerresheimer acquires Wilden Group

The German drug-delivery systems company Wilden has been acquired by Gerresheimer.

Wilden is a market and technology leader for innovative plastic systems, Gerresheimer says. The business comprises the divisions of Medical Plastic Systems (pharmaceutics, diagnostics, medical technology and consumer healthcare) and Technical Plastic Systems.

'This marks a giant step in our strategy to generate sustained growth through the acquisition of technology and market leaders in the field of pharma packaging and systems', said Gerresheimer ceo Axel Herberg.

Wilden has eight production plants and four joint ventures and more than 2,300 employees, with a customer base among globally active pharma and healthcare groups.

Three quarters of Gerresheimer's sales are today already achieved with pharma/life-science customers, the company reports.

As a result of the purchase Gerresheimer will in future have more than 31 production plants in America, Europe and Asia and a worldwide total of 8,500 employees.